HSBA

1,170.2

+4.31%↑

LLOY

92.64

+5.46%↑

BARC

380.25

+4.93%↑

LSE

8,540

-0.07%↓

STAN

1,559.5

+5.62%↑

HSBA

1,170.2

+4.31%↑

LLOY

92.64

+5.46%↑

BARC

380.25

+4.93%↑

LSE

8,540

-0.07%↓

STAN

1,559.5

+5.62%↑

HSBA

1,170.2

+4.31%↑

LLOY

92.64

+5.46%↑

BARC

380.25

+4.93%↑

LSE

8,540

-0.07%↓

STAN

1,559.5

+5.62%↑

HSBA

1,170.2

+4.31%↑

LLOY

92.64

+5.46%↑

BARC

380.25

+4.93%↑

LSE

8,540

-0.07%↓

STAN

1,559.5

+5.62%↑

HSBA

1,170.2

+4.31%↑

LLOY

92.64

+5.46%↑

BARC

380.25

+4.93%↑

LSE

8,540

-0.07%↓

STAN

1,559.5

+5.62%↑

Search

IP Group PLC

Fechado

51.5 0.39

Visão Geral

Variação de preço das ações

24h

Atual

Mín

48

Máximo

52.1

Indicadores-chave

By Trading Economics

Rendimento

-43M

Vendas

-40M

EPS

-0.046

Margem de lucro

107.769

Funcionários

69

EBITDA

-45M

Recomendações

By TipRanks

Recomendações

Comprar

Previsão para 12 meses

+105.88% upside

Estatísticas de Mercado

By TradingEconomics

Capitalização de Mercado

435M

Abertura anterior

51.11

Fecho anterior

51.5

IP Group PLC Gráfico

O desempenho passado não é um indicador confiável de resultados futuros.

Notícias Relacionadas

23 de mar. de 2026, 23:47 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead Sciences to Buy Ouro Medicines, Collaborate With Galapagos on Purchased Assets -- Update

23 de mar. de 2026, 22:55 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead Sciences to Buy Ouro Medicines for Up to $2.18 Billion

23 de mar. de 2026, 21:51 UTC

Aquisições, Fusões, Aquisições de Empresas

Italy's Postal Service Makes $12.50 Billion Bid for Telecom Italia -- 3rd Update

23 de mar. de 2026, 23:59 UTC

Conversa de Mercado

Global Equities Roundup: Market Talk

23 de mar. de 2026, 23:59 UTC

Conversa de Mercado

Woodside, Santos Earnings Power Up on Surging LNG Prices -- Market Talk

23 de mar. de 2026, 23:50 UTC

Conversa de Mercado

Nikkei May Rise on Hopes for U.S. Talks With Iran -- Market Talk

23 de mar. de 2026, 23:37 UTC

Conversa de Mercado

Gold Rises, Boosted by Fall in Dollar, U.S. Treasury Yields -- Market Talk

23 de mar. de 2026, 22:42 UTC

Conversa de Mercado
Notícias Principais

Global Equities Roundup: Market Talk

23 de mar. de 2026, 22:42 UTC

Conversa de Mercado
Notícias Principais

Bell Potter Names Miners Less Exposed to Fuel Price, Supply Risks -- Market Talk

23 de mar. de 2026, 22:40 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead Sciences to Buy Ouro Medicines for Up to $2.18B

23 de mar. de 2026, 22:23 UTC

Conversa de Mercado

Apollo Debt Solutions Shrugs Off Private-Credit Fears -- Market Talk

23 de mar. de 2026, 22:22 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead Sciences: OM336 Is for Treatment of Autoantibodies Driven Immune-Mediated Disease

23 de mar. de 2026, 22:21 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead Sciences: Company Would Pay Galapagos Royalties of 20%-23% of Net OM336 Sales

23 de mar. de 2026, 22:21 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead Sciences: Company Would Retain Sole Worldwide Commercialization Rights of OM336 Outside of Greater China

23 de mar. de 2026, 22:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead Sciences: Company, Galapagos Would Collaborate on Development of OM336 >GILD

23 de mar. de 2026, 22:20 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead Sciences: Galapagos Would Absorb Substantially All of Ouro's Operating Assets, Retain Its Employees >GILD

23 de mar. de 2026, 22:19 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead Sciences: Galapagos Would Pay 50% of Upfront Consideration and 50% of Any Contingent Milestone Payments Payable to Ouro Shareholders

23 de mar. de 2026, 22:19 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead Sciences: Currently in Advanced Discussions With Galapagos With Respect to Potential Research-and-Development Collaboration on Acquired Ouro Assets

23 de mar. de 2026, 22:18 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead Sciences to Buy Ouro Medicines for About $1.68B Upfront, Up to $500M in Contingent Milestone Payments >GILD

23 de mar. de 2026, 22:15 UTC

Aquisições, Fusões, Aquisições de Empresas

Gilead Sciences To Acquire Ouro Medicines To Advance First In Class T Cell Engager Program For Autoimmune Diseases >GILD

23 de mar. de 2026, 22:08 UTC

Conversa de Mercado

Ebos Needs to Reset Its Gearing Targets -- Market Talk

23 de mar. de 2026, 21:42 UTC

Conversa de Mercado

Global Forex and Fixed Income Roundup: Market Talk

23 de mar. de 2026, 21:42 UTC

Conversa de Mercado

RBNZ's Breman Strikes Reassuring Tone On Rates -- Market Talk

23 de mar. de 2026, 21:32 UTC

Ganhos

WuXi XDC Cayman: Results Aided by Strong Growth in Contract Research, Development and Manufacturing Organisation Business>2268.HK

23 de mar. de 2026, 21:32 UTC

Ganhos

WuXi XDC Cayman 2025 Net CNY1.56B Vs. Net CNY917.16M >2268.HK

23 de mar. de 2026, 21:32 UTC

Ganhos

WuXi XDC Cayman 2025 Rev CNY5.94B Vs. CNY4.05B >2268.HK

23 de mar. de 2026, 21:10 UTC

Notícias Principais

Oil Is Back Under $100. Trump Says Iran Has Agreed to No Nuclear Weapons. -- Barrons.com

23 de mar. de 2026, 20:50 UTC

Conversa de Mercado

Tech, Media & Telecom Roundup: Market Talk

23 de mar. de 2026, 20:50 UTC

Conversa de Mercado

Health Care Roundup: Market Talk

23 de mar. de 2026, 20:50 UTC

Conversa de Mercado
Ganhos
Notícias Principais

Basic Materials Roundup: Market Talk

Comparação entre Pares

Variação de preço

IP Group PLC Previsão

Preço-alvo

By TipRanks

105.88% parte superior

Previsão para 12 meses

Média 105 GBX  105.88%

Máximo 110 GBX

Mínimo 100 GBX

Com base em 2 analistas de Wall Street que oferecem metas de preço de 12 meses para IP Group PLC - Dist nos últimos 3 meses.

Consenso de Avaliação

By TipRanks

Comprar

2 ratings

2

Comprar

0

Manter

0

Vender

Informação Financeira

Custos administrativos e de venda

Custos Operacionais

Lucro antes de imposto

Vendas

Custo das vendas

Lucro bruto sobre vendas

Despesa com juros da dívida

EBITDA

Resultado Operacional

$

Sobre IP Group PLC

IP Group Plc is a private equity and venture capital firm specializing in seed/startup, early venture, emerging growth, mature, mid venture, late venture, incubation, mezzanine in growth capital companies. It prefers to invest in energy, materials, healthcare, information technology, communication services, utilities, life sciences, deeptech, cleantech, chemicals, science and innovation companies. The firm prefers to invest in Europe. It firm prefers to invest between £0.050 million ($0.08 million) and £1.25 million ($2.01 million) with revenue up to £45 million ($71 million). IP Group Plc was founded in 2001 and is based in London, United Kingdom with additional offices in Hong Kong S.A.R., Hong Kong and Melbourne, Australia.
help-icon Live chat